|
ATX-295 and bevacizumab (or biosimilar) Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1/2: 1
Top Sponsors
- Accent Therapeutics1
Indications
- sqNSCLC1
- High-grade Serous Ovarian Carcinoma1
- Breast Cancer Recurrent1
- Squamous Non-small-cell Lung Cancer1
- Triple Negative Breast Cancer1
Aurora, Colorado1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.